MagForce AG, a medical device company, operates in the field of nanotechnology-based cancer treatment in Germany. The company offers NanoTherm therapy that treats solid tumors through the intratumoral generation of heat by activating superparamagnetic nanoparticles. It also provides NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nanopracticles that is activated in an alternating magnetic field; NanoPlan, a treatment planning software; and NanoActivator, a magnetic field applicator for therapy. The company was founded in 1997 and is headquartered in Berlin, Germany.

Company Growth (employees)
Berlin, DE
Size (employees)
29 (est)
MagForce was founded in 1997 and is headquartered in Berlin, DE

Key People/Management at MagForce

Ben Lipps

Ben Lipps

Hoda Tawfik

Hoda Tawfik


MagForce Office Locations

MagForce has offices in Berlin and Planegg
Berlin, DE (HQ)
3 Max-Planck-Straße
Planegg, DE
7 Bunsenstraße
Show all (2)

MagForce Financials and Metrics

MagForce Financials


Market capitalization (30-Oct-2017)

200.5 m

Closing share price (30-Oct-2017)

MagForce's current market capitalization is €200.5 m.
Show all financial metrics

MagForce Market Value History

MagForce's Web-traffic and Trends

MagForce News and Updates

Global Nano Chemotherapy Market Size, Share And Industry Forecast 2022

"The Latest Research Report Global Nano Chemotherapy Market Size, Status and Forecast 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" Posted via Industry Today. Follow us on Twitter @IndustryTod…

MagForce Company Life and Culture

You may also be interested in